Leukemia, Myeloid, Acute

"Leukemia, Myeloid, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Descriptor ID	D015470
MeSH Number(s)	C04.557.337.539.275
Concept/Terms	Leukemia, Myeloid, Acute Leukemia, Myeloid, Acute Acute Myeloid Leukemia Acute Myeloid Leukemias Leukemias, Acute Myeloid Myeloid Leukemias, Acute ANLL Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Myeloblastic, Acute Leukemia, Myelocytic, Acute Leukemia, Myelogenous, Acute Leukemia, Nonlymphoblastic, Acute Leukemia, Nonlymphocytic, Acute Myeloblastic Leukemia, Acute Acute Myeloblastic Leukemia Acute Myeloblastic Leukemias Leukemia, Acute Myeloblastic Leukemias, Acute Myeloblastic Myeloblastic Leukemias, Acute Myelocytic Leukemia, Acute Acute Myelocytic Leukemia Acute Myelocytic Leukemias Leukemia, Acute Myelocytic Leukemias, Acute Myelocytic Myelocytic Leukemias, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Nonlymphoblastic Leukemia, Acute Acute Nonlymphoblastic Leukemia Acute Nonlymphoblastic Leukemias Leukemia, Acute Nonlymphoblastic Leukemias, Acute Nonlymphoblastic Nonlymphoblastic Leukemias, Acute Nonlymphocytic Leukemia, Acute Acute Nonlymphocytic Leukemia Acute Nonlymphocytic Leukemias Leukemia, Acute Nonlymphocytic Leukemias, Acute Nonlymphocytic Nonlymphocytic Leukemias, Acute Acute Myelogenous Leukemia Acute Myelogenous Leukemias Leukemias, Acute Myelogenous Myelogenous Leukemias, Acute Myeloid Leukemia, Acute, M1 Myeloid Leukemia, Acute, M1 Leukemia, Myeloid, Acute, M1 Acute Myeloid Leukemia without Maturation Leukemia, Myeloid, Acute, M2 Leukemia, Myeloid, Acute, M2 Myeloid Leukemia, Acute, M2 Acute Myeloid Leukemia with Maturation

Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Acute".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Leukemia [C04.557.337]
Leukemia, Myeloid [C04.557.337.539]
Leukemia, Myeloid, Acute [C04.557.337.539.275]

Below are MeSH descriptors whose meaning is related to "Leukemia, Myeloid, Acute".

Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Acute".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Leukemia, Myeloid, Acute" by people in this website by year, and whether "Leukemia, Myeloid, Acute" was a major or minor topic of these publications.

Bar chart showing 36 publications over 16 distinct years, with a maximum of 6 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
2000	1	1	2
2001	1	0	1
2004	2	0	2
2005	0	2	2
2008	1	0	1
2009	1	0	1
2012	2	1	3
2013	1	0	1
2015	2	0	2
2016	0	1	1
2019	4	0	4
2020	5	0	5
2021	6	0	6
2022	3	0	3
2023	1	0	1

Below are the most recent publications written about "Leukemia, Myeloid, Acute" by people in Profiles.

Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia. Am J Hematol. 2023 04; 98(4):608-619.

View in: PubMed
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia. 2023 05; 37(5):1006-1017.

View in: PubMed
Transplantation provides superior survival high risk myeloid malignancies in older patients. Leuk Lymphoma. 2022 10; 63(10):2494-2498.

View in: PubMed
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Adv. 2022 01 08; 6(3):828-847.

View in: PubMed
Type 1 interferon to prevent leukemia relapse after allogeneic transplantation. Blood Adv. 2021 12 14; 5(23):5047-5056.

View in: PubMed
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone Marrow Transplant. 2021 12; 56(12):3068-3077.

View in: PubMed
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS). Cancer. 2021 12 01; 127(23):4421-4431.

View in: PubMed
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults. Transplant Cell Ther. 2021 11; 27(11):923.e1-923.e12.

View in: PubMed
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. 2021 08 01; 106(8):2295-2296.

View in: PubMed
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2021 09; 56(9):2108-2117.

View in: PubMed

People

Explore

Similar Concepts

Top Journals